IDH1 Inhibitor AB-218 in Patients With Advanced IDH1 Mutant Cholangiocarcinoma and Other Solid Tumor

Clinical trial NCT05814536 · TERMINATED

Trial details

NCT number: NCT05814536
Sponsor: AnHeart Therapeutics Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Cholangiocarcinoma With IDH1 Mutation Solid Tumors With IDH1 Mutation

Start date: 2023-05-06
Primary completion: 2024-08-15
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.